Lantheus Statistics
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
100.18+0.23 (+0.23%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Lantheus by the numbers
Lantheus has a market capitalization of $6.54 billion based on 65.30M shares outstanding. Its trailing P/E ratio is 24.3, and its forward P/E is 15.7. The stock trades 0.3% below its 50-day average and 13.3% above its 200-day average.
Average daily trading volume is 1.34M shares, or about $133.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LNTH valuation vs. peer median
| Metric | LNTH | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.54B | $1.24B | +426% |
| Avg. volume | 1.34M | 1.46M | -9% |
Peer median across 8 companies: ORKA, NEOG, CLDX, NTLA, QDEL, ACHV, TKNO, MYGN.
Valuation
- Market cap
- $6.54B
- P/E (TTM)
- 24.26
- Forward P/E
- 15.71
- Price / sales (latest FY)
- 4.24
- EPS (TTM)
- $4.13
- Shares outstanding
- 65.30M
Price and trading
- Previous close
- 99.95
- Open
- 100.20
- Day range
- 100.02 – 100.33
- 52-week range
- 50.16 – 111.86
- 52-week change
- +93.25%
- 50-day moving average
- 100.53
- Beta
- —
- Volume
- 553.78K
- Average volume
- 1.34M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 6.54B
- Pe
- 24.26
- Forward Pe
- 15.71
- Eps
- 4.13
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 111.86
- Week52 Low
- 50.16
- Avg Volume
- 1.34M
- Shares Outstanding
- 65.30M
- Ma50
- 100.53
- Ma200
- 88.42
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -10.44%
- Pct From52w Low
- 99.74%